Page last updated: 2024-10-22

6-acetylaminocaproic acid and Pulmonary Fibrosis

6-acetylaminocaproic acid has been researched along with Pulmonary Fibrosis in 2 studies

6-acetylaminocaproic acid: wound-healing agent component of plasmutan

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
"Acexamic acid is currently used to avoid pulmonary fibrosis in patients treated with bleomycim."1.26[So-called refractory hypoxemia: treatment with acexamic acid]. ( Barale, F; Berthout, P; Boillot, A; Bourgeois, F; Daoudal, P, 1979)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bronner, G1
Litzler, A1
Conraux, C1
Daoudal, P1
Boillot, A1
Berthout, P1
Bourgeois, F1
Barale, F1

Other Studies

2 other studies available for 6-acetylaminocaproic acid and Pulmonary Fibrosis

ArticleYear
[Anti-pulmonary fibrosis effect of acexamic acid in bleomycin therapy].
    Journal francais d'oto-rhino-laryngologie; audiophonologie, chirurgie maxillo-faciale, 1980, Volume: 29, Issue:7

    Topics: Aminocaproates; Aminocaproic Acid; Animals; Antifibrinolytic Agents; Bleomycin; Drug Therapy, Combin

1980
[So-called refractory hypoxemia: treatment with acexamic acid].
    La Nouvelle presse medicale, 1979, Dec-03, Volume: 8, Issue:47

    Topics: Adolescent; Adult; Aminocaproates; Aminocaproic Acid; Bleomycin; Female; Humans; Hypoxia; Male; Midd

1979